Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenge of immune-mediated adverse reactions in the emergency department
Gregory A. Daniels, Angela D. Guerrera, Donna Katz, et al.
Emergency Medicine Journal (2019) Vol. 36, Iss. 6, pp. 369-377
Open Access | Times Cited: 16

Showing 16 citing articles:

Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bhighCD27low memory-like NK cells
Alaa M. Khalifa, Takashi Nakamura, Yusuke Sato, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors
Ondřej Fiala, Ondřej Šorejs, Jan Šustr, et al.
Anticancer Research (2020) Vol. 40, Iss. 3, pp. 1219-1227
Open Access | Times Cited: 28
Ternary Regulation of Tumor Microenvironment by Heparanase‐Sensitive Micelle‐Loaded Monocytes Improves Chemo‐Immunotherapy of Metastatic Breast Cancer
Tianqun Lang, Zhong Zheng, Xin Huang, et al.
Advanced Functional Materials (2020) Vol. 31, Iss. 10
Closed Access | Times Cited: 22
Efectos adversos de la inmunoterapia oncohematológica: implicaciones para la Atención Primaria y la continuidad asistencial
C. Vidal Lopez, G.L. Ríos Quito, C. Salom Garrigues, et al.
Medicina de Familia SEMERGEN (2019) Vol. 46, Iss. 1, pp. 60-67
Closed Access | Times Cited: 11
Acute renal transplant rejection following nivolumab therapy for metastatic melanoma
Brandon Tan, Mark Baxter, Richard Casasola
BMJ Case Reports (2021) Vol. 14, Iss. 2, pp. e238037-e238037
Open Access | Times Cited: 9
Immunotherapy in the frontline management of advanced and metastatic NSCLC
Jennifer Potash, Rachelle Laliberte, Paul M. Silverman, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 18, pp. S323-S332
Open Access | Times Cited: 6
A Nurse Practitioner-Led Model to Implement and Deliver Unscheduled Emergency Cancer Care
Adam McCavery
The Journal for Nurse Practitioners (2020) Vol. 16, Iss. 4, pp. 271-275
Closed Access | Times Cited: 5
Onco-Primary Care of Patients Receiving Immune Checkpoint Inhibitors
Christopher Hoimes, Suzanne McGettigan, Lee Schwartzberg
The American Journal of Medicine (2024) Vol. 137, Iss. 12, pp. 1200-1209
Open Access
Perioperative Implications of Biologics and Immunotherapy
Olakunle Idowu, Alexandra Lewis, C Doyle
Advances in Anesthesia (2024) Vol. 42, Iss. 1, pp. 97-113
Closed Access
Nivolumab Safety in Renal Cell Carcinoma: A Case Report
James Debono, Dustin Balzan, John-Joseph Borg, et al.
Journal of Pharmacy Technology (2023) Vol. 40, Iss. 2, pp. 112-117
Closed Access | Times Cited: 1
An Evaluation of the Use of Corticosteroids for the Management of Immune-Mediated Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
Adrian Tsui, Lindsay Edmondson, Justin Julius
Journal of the Advanced Practitioner in Oncology (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
Abdulaali R. Almutairi, Brian L. Erstad, Ali McBride, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 4, pp. 489-497
Closed Access | Times Cited: 2
What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report
Thomas Butters, Wing Kin Liu, Michael J. Grant, et al.
International Journal of Cancer Management (2021) Vol. 14, Iss. 8
Open Access | Times Cited: 2
Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis
Leilei Fang, Changqin Liu, Xiaomin Sun, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
The impact of immune checkpoint inhibitors on cost and quality of life in the initial treatment of patients with advanced or metastatic NSCLC
Kelly Marie Procailo
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 18, pp. S333-S339
Open Access | Times Cited: 1
Routine antibiotics in the febrile cancer patient: should immune checkpoint inhibitors affect our practice?
Katie Walker, Kathryn Yu, Zhi Shyuan Seraphina Choong, et al.
Emergency Medicine Journal (2020) Vol. 38, Iss. 1, pp. 85-86
Closed Access
Page 1

Scroll to top